Overview

UnitedHealth Group Incorporated (NYSE: UNH) is the largest health insurance company in the United States and the largest private company by revenue on the Fortune 500, with over $370 billion in annual revenue. Headquartered in Eden Prairie, Minnesota, the company operates through two primary divisions: UnitedHealthcare (insurance) and Optum (health services, pharmacy benefits, physician groups, and health technology). UnitedHealthcare insures approximately 49 million Americans and is the nation’s largest Medicare Advantage contractor.

This profile documents UnitedHealth Group’s documented Freedom 250 sponsorship while the company simultaneously depends on favorable rate-setting from the Trump administration’s Centers for Medicare & Medicaid Services (CMS) and faces an ongoing Department of Justice antitrust investigation into its vertically integrated business model. In April 2026, the Trump administration’s CMS finalized Medicare Advantage rates $13 billion higher than initially proposed — following what Healthcare Dive described as “a full-court lobbying press from the insurance industry.”

Basis for Inclusion

Subject Classification: Public Corporation with documented political spending while dependent on favorable government rate-setting and subject to active federal investigation.

Basis for inclusion:

• Documented sponsor of Freedom 250, the public-private partnership funding Trump’s Fourth of July and semiquincentennial events. Sponsor packages at the $1M+ “Patriot” level include private receptions with the president (PolitiFact, June 2026; Impactivize; GMA/Schiff probe).
• Largest Medicare Advantage contractor in the U.S. — its revenue is directly dependent on CMS rate-setting decisions made by Trump-appointed administrators.
• $12.54 million in federal lobbying expenditures in 2025, nearly doubling from $7.52 million in 2024 (OpenSecrets; Payer Perspectives).
• Subject of ongoing DOJ antitrust investigation into the relationship between UnitedHealthcare and Optum (Wall Street Journal, February 2024; Healthcare Dive).
• 88% of UnitedHealth Group’s 43 registered lobbyists in 2024 previously held government positions (OpenSecrets revolving door data).
• $792,500 in PAC contributions to federal candidates in the 2023–2024 cycle (54% Republican, 45% Democrat) (OpenSecrets).

What is NOT the basis for inclusion:

• The murder of CEO Brian Thompson (December 2024) — this is contextual background, not a basis for accountability.
• Routine health insurance claims processing or coverage decisions.
• Individual employee political contributions.
• UnitedHealth’s stock performance.

Political Spending and Access

Freedom 250 Sponsorship

UnitedHealth Group is listed as a corporate sponsor of Freedom 250, appearing on the organization’s website alongside other major corporations including ExxonMobil, Mastercard, Deloitte, and Palantir. The company has not publicly disclosed the amount of its contribution.

Freedom 250 sponsor packages at the $1 million+ “Patriot” level include invitations to a “private Freedom 250 thank you reception” hosted by President Trump, with a “historic photo opportunity.” Those giving $2.5 million or more receive speaking roles at government-associated events (New York Times; Senator Schiff letter, February 2026).

SourcePolitiFact, June 1, 2026; Impactivize, May 2026; Senator Schiff probe, February 2026.UnitedHealth Group has not responded to press inquiries about its Freedom 250 sponsorship (Impactivize, May 2026).

Lobbying Expenditures

UnitedHealth Group’s lobbying spending surged 67% in 2025 — the first year of Trump’s second term and a critical period for Medicare Advantage rate-setting.

SourceOpenSecrets, UnitedHealth Group Lobbying Profile; Payer Perspectives, “Health Care Giants Pour Millions Into D.C. Lobbying,” January 2026.Of the company’s 43 registered lobbyists in 2024, 38 (88%) previously held government positions — among the highest revolving-door percentages of any major lobbying client.

PAC Contributions

SourceOpenSecrets, PAC Profile: UnitedHealth Group, 2023–2024.The UnitedHealth Group PAC raised $3.14 million and spent $2.97 million in the 2023–2024 cycle, contributing $792,500 to federal candidates (54.32% to Republicans, 45.11% to Democrats).

Medicare Advantage: The Core Business Interest

How CMS Rate-Setting Works

Medicare Advantage (MA) is the privatized version of Medicare, in which the federal government pays private insurers a per-enrollee capitated rate to provide Medicare benefits. CMS sets these rates annually through a process that includes an Advance Notice (proposed rates) followed by a Final Rate Announcement. The difference between proposed and final rates can represent billions of dollars in insurer revenue.

UnitedHealthcare is the largest MA contractor, leading enrollment in most U.S. counties.

The 2027 Rate Sequence

Healthcare Dive reported: “The Trump administration finalized significantly higher Medicare Advantage rates for 2027 than it had proposed after a full-court lobbying press from the insurance industry.”

JustCare noted that CMS released the favorable final rates “just minutes after the New York Stock Exchange closed… knowing its announcement would [boost] earnings for Big Insurance.”

SourceHealthcare Dive, April 2026; JustCare, April 2026; CMS 2027 Rate Announcement; The Hertel Report, April 2026; FinancialContent, January 27, 2026.The independent Medicare Payment Advisory Commission (MedPAC) estimated that MA overpayments — resulting from the way insurers document patient conditions to increase reimbursement — totaled $76 billion in 2026.

DOJ Antitrust Investigation

Ongoing Investigation (2024–Present)

The Department of Justice launched an antitrust investigation into UnitedHealth Group in early 2024, as reported by the Wall Street Journal on February 27, 2024. The investigation examines:

• Whether the relationship between UnitedHealthcare (insurance) and Optum (provider network, pharmacy benefits) creates anticompetitive effects
• Whether Optum’s acquisition of physician groups disadvantages rival providers
• Whether UnitedHealthcare favors Optum-owned groups in contracting, squeezing out rival physicians
• UnitedHealth’s Medicare billing and documentation practices

SourceWall Street Journal, February 27, 2024; Healthcare Dive; Health Capital Topics, April 2024.The investigation began under the Biden administration but continues under Trump-appointed leadership.

Amedisys Acquisition Settlement (2025–2026)

The DOJ challenged UnitedHealth’s $3.3 billion acquisition of Amedisys (home health and hospice). A federal court approved a settlement in April 2026 requiring:

• Divestiture of 164 home health and hospice facilities across 19 states
• $528 million in annual revenue to be divested
• $1.1 million civil penalty for Amedisys’s false certification under the Hart-Scott-Rodino Act
• The largest divestiture of outpatient healthcare services to resolve a merger challenge (by number of facilities)

SourceDOJ Office of Public Affairs, April 15, 2026.

Change Healthcare Acquisition (2022)

The DOJ attempted to block UnitedHealth’s acquisition of Change Healthcare in 2022, arguing it would give the company access to sensitive competitor data and near-monopolistic control of claims processing. A federal judge allowed the acquisition to proceed. In February 2024, Change Healthcare was hit by a ransomware attack that compromised protected health information of at least 100 million people and cost UnitedHealth $872 million.

Insider Trading Lawsuit

SourceHealthcare Finance News, December 2024; CNBC, December 4, 2024.A class-action lawsuit (Hollywood Firefighters Pension Fund v. UnitedHealth Group) alleges that company executives — including the late CEO Brian Thompson and Chairman Stephen Hemsley — sold over $120 million in personally held shares between October 2023 and February 2024 while aware of the DOJ investigation but before it became public. Thompson allegedly sold $15.1 million in shares; Hemsley allegedly sold over $102 million.

The Murder of Brian Thompson

On December 4, 2024, UnitedHealthcare CEO Brian Thompson was fatally shot outside the New York Hilton Midtown in what the NYPD described as “a brazen, targeted attack.” Luigi Mangione was charged with the murder. Shell casings at the scene reportedly bore the words “deny,” “defend,” and “depose” — a reference to insurance industry claim denial practices.

SourceCNBC, December 4, 2024; Wikipedia, “Killing of Brian Thompson”; CBS Minnesota.The killing prompted widespread public discussion about health insurance industry practices, with over 100,000 Facebook users responding to UnitedHealth’s condolence post with “laughing” reactions. The incident is included as contextual background documenting the political environment surrounding UnitedHealth at the time of its Freedom 250 sponsorship — not as a basis for this profile’s inclusion.

Conflict of Interest Analysis

The factual record documents the following:

1. UnitedHealth Group is the largest Medicare Advantage contractor in the United States. Its revenue depends directly on CMS rate-setting decisions made by Trump administration appointees.
2. In January 2026, CMS proposed a nearly flat rate increase (0.09%) — devastating to UnitedHealth’s stock.
3. UnitedHealth and the industry conducted an intensive lobbying campaign, spending $12.54 million on federal lobbying in 2025.
4. By April 2026, CMS finalized rates $13 billion higher than initially proposed.
5. During this same period, UnitedHealth is a documented Freedom 250 sponsor — contributing to an entity that provides donors with private access to President Trump.
6. Also during this period, UnitedHealth faces an ongoing DOJ antitrust investigation that could fundamentally alter its vertically integrated business model.
7. 88% of the company’s lobbyists previously held government positions.

The temporal overlap between Freedom 250 sponsorship, the $13 billion rate increase, and the ongoing DOJ investigation represents a documented intersection of political spending and government decisions affecting the sponsor.

For Trump Supporters: Questions Worth Considering

1. When CMS proposed flat MA rates in January 2026, the industry spent millions lobbying — and rates came back $13 billion higher. Who pays for that $13 billion? (Answer: taxpayers and Medicare beneficiaries.)
2. MedPAC estimates MA overpayments at $76 billion annually. Should a company benefiting from those overpayments also be writing checks to the president’s private fundraising entity?
3. The DOJ investigation into UnitedHealth continues under Trump. Does the Freedom 250 sponsorship create pressure — real or perceived — on prosecutors?
4. Should companies with pending federal investigations be permitted to sponsor entities that provide private access to the president?
5. President Trump has championed “Make America Healthy Again.” How does a $13 billion payment increase to the insurance industry serve that goal?

Investigative Trails

• CMS rate-setting timeline: proposed vs. final rates and the intervening lobbying activity
• DOJ antitrust investigation: status under Trump-appointed leadership vs. initiation under Biden
• MedPAC overpayment data: coding practice manipulation in Medicare Advantage
• Freedom 250 donor tier documents and UnitedHealth’s specific contribution level
• Revolving door analysis: which former CMS/HHS officials now lobby for UnitedHealth
• Insider trading lawsuit status and DOJ response
• Congressional testimony: January 22, 2026 hearing where insurer CEOs testified before House committees
• OpenSecrets lobbying disclosure: specific issues lobbied on in 2025

Investigative trail pointers (public records)

Education only — verify independently. Absence of hits is not proof.

Use public-records-research-specialist, corporate-intelligence-investigator, and public-corruption-ombudsman evidence tiers.

Sources

1. PolitiFact, “Trump’s Freedom 250 concert on the National Mall: What happened? What’s next?” June 1, 2026. https://www.politifact.com/article/2026/jun/01/cancel-250-concert-national-mall-trump/
2. Impactivize, “Freedom 250 spokesperson says Trump’s hijack of America’s birthday is ‘inherently nonpolitical,'” May 2026. https://www.impactivize.org/impactivizereporting/freedom-250-spokesperson-says-trumps-hijack-of-americas-birthday-is-inherently-nonpolitical-as-performers-drop-out-saying-they-were-misled/
3. Healthcare Dive, “CMS finalizes higher Medicare Advantage rates for 2027 in gift to insurers,” April 2026. https://www.healthcaredive.com/news/cms-finalizes-higher-medicare-advantage-rates-2027/816633/
4. JustCare, “Trump administration bolsters Medicare Advantage insurer overpayments in 2027,” April 2026. https://justcareusa.org/trump-administration-bolsters-medicare-advantage-insurer-overpayments-in-2027/
5. CMS, “2027 Medicare Advantage and Part D Rate Announcement,” April 2026. https://www.cms.gov/newsroom/fact-sheets/2027-medicare-advantage-part-d-rate-announcement
6. FinancialContent, “Medicare Shock: UnitedHealth Plummets 19%,” January 27, 2026. https://www.financialcontent.com/article/marketminute-2026-1-27-medicare-shock-unitedhealth-plummets-19-as-trump-administration-tightens-reins-on-private-medicare
7. Healthcare Dive, “UnitedHealth under antitrust investigation by DOJ: reports,” February 2024. https://www.healthcaredive.com/news/unitedhealth-antitrust-investigation-doj-unitedhealthcare-optum/708727/
8. DOJ, “Justice Department Requires Broad Divestitures to Resolve Challenge to UnitedHealth’s Acquisition of Amedisys,” updated April 15, 2026. https://www.justice.gov/opa/pr/justice-department-requires-broad-divestitures-resolve-challenge-unitedhealths-acquisition
9. DOJ, “Court Approves Justice Department’s Settlement in UnitedHealth Group and Amedisys Merger,” April 15, 2026. https://www.justice.gov/opa/pr/court-approves-justice-departments-settlement-unitedhealth-group-and-amedisys-merger
10. CNBC, “UnitedHealthcare CEO Brian Thompson fatally shot in New York,” December 4, 2024. https://www.cnbc.com/2024/12/04/unitedhealth-cancels-investor-day-after-reports-of-executive-shot-in-manhattan.html
11. Healthcare Finance News, “Brian Thompson named in lawsuit alleging insider trading,” December 2024. https://www.healthcarefinancenews.com/news/brian-thompson-named-lawsuit-alleging-insider-trading
12. OpenSecrets, “UnitedHealth Group Profile: Summary.” https://www.opensecrets.org/orgs/unitedhealth-group/summary?id=D000000348
13. Payer Perspectives, “Health Care Giants Pour Millions Into D.C. Lobbying,” January 2026. https://payerperspectives.substack.com/p/health-care-giants-pour-millions
14. OpenSecrets, “PAC Profile: UnitedHealth Group,” 2023–2024. https://www.opensecrets.org/political-action-committees-pacs/unitedhealth-group/C00274431/summary/2024
15. Senator Schiff, “Probe into New Private Entity Offering Millionaire Trump Donors Access,” February 2026. https://www.schiff.senate.gov/news/press-releases/news-senator-schiff-colleagues-launch-probe-into-new-private-entity-offering-millionaire-trump-donors-access-to-white-house-semiquincentennial-events/
16. The Hertel Report, “CMS Boosts 2027 Medicare Advantage Rates Amid Industry Pressure,” April 2026. https://www.thehertelreport.com/cms-boosts-2027-medicare-advantage-rates-amid-industry-pressure/
17. Health Capital Topics, “DOJ Antitrust Reportedly Investigating UnitedHealth Group,” April 2024. https://www.healthcapital.com/hcc/newsletter/04_24/HTML/DOJ/convert_doj_antitrust_probe_unitedhealth_topics.php

Factual correction requests: If you believe information in this profile is incorrect, please contact factcheck@patriot.university with your name (optional), the specific claim, and any supporting documentation. We review all submissions and correct verified errors promptly.